At referral, AAV patients often have a multitude of symptoms, including renal disease, fatigue and fevers. To learn more about these symptoms and how common they are, visit https://t.co/TOVJpUTIpB
#AAV#ANCA#vasculitis#raredisease
Hear the story of vasculitis patient and former rheumatologist Shanali, who turned to art after her diagnosis. The work of Shanali was central to the development of the patient disease awareness initiative: SEE ME. HEAR ME
For more stories visit https://t.co/6OzRn2ndmG
#AAV
With advice and information covering all aspects of AAV, the HCP Dialogue Tool provides a perfect resource to help patients discuss their condition with their doctors and make the most of their appointments. See more at https://t.co/TOVJpUTIpB #AAV#ANCA#vasculitis#raredisease
Minor relapse is an under-recognised clinical problem for AAV patients when receiving remission induction therapy, leading to prolonged glucocorticoid use in the long term. Find out more at https://t.co/ebVvoabZqK
#AAV#ANCA#vasculitis#raredisease
The often lengthy path to diagnosis means AAV patients may already have specific organ damage and risk of mortality by the time they've received a diagnosis and started treatment. Find out more about disease burden at https://t.co/TOVJpUTIpB
#AAV#ANCA#vasculitis#raredisease
Our current understanding of ANCA-associated vasculitis (AAV) is rapidly evolving. Visit https://t.co/pT4MUjBUfE to read key research papers and keep up with the latest clinical data in AAV.
#AAV#ANCA#vasculitis#raredisease
GPA and MPA are the most common clinical subtypes of ANCA-associated vasculitis. Learn more about the incidence and prevalence of AAV at: https://t.co/ZOd7Sf9OQm
#AAV#Vasculitis#RareDisease
Living with a rare disease like AAV can leave patients feeling uninformed as they manage their disease. Why not direct them to our Patient Brochure at https://t.co/6OzRn2ndmG which contains interviews and advice from HCPs and patients.
#AAV#ANCA#vasculitis#raredisease
ANCA-associated vasculitis patients often experience a long pathway to diagnosis. This is because most patients go through referrals and therefore may see several physicians before a diagnosis is made. Visit https://t.co/ebVvoabrBc to find out more
#AAV#ANCA#Vasculitis
Do you want to learn more about AAV in a different way? With AAV World, the interactive tool, you can explore the challenges faced by AAV patients, like organ damage and quality of life. Learn more at https://t.co/TOVJpUTIpB
#AAV#ANCA#vasculitis#raredisease
Did you know that as a systemic disease, AAV can impact many organs, including lungs, kidneys, skin, ears and eyes? Find out about all of the ways in which AAV can impact your patients by exploring: https://t.co/TOVJpUTIpB
#AAV#ANCA#vasculitis#raredisease
With patient-friendly language and simplified science, the Dialogue Tool helps make all things AAV understandable for your patients, meaning they can get the best outcomes from appointments. Take a look today at: https://t.co/TOVJpUUgf9
#AAV#ANCA#vasculitis#raredisease
Whether it's fatigue sleep disturbance or anxiety AAV can affect the quality of life of your patients in a variety of ways and that's just one impact of the disease. Learn more about the wide-reaching burden of AAV at: https://t.co/TOVJpVbjh9
#AAV#ANCA#vasculitis#raredisease
C5a is a protein within the complement system that amplifies ANCA-induced inflammation and vascular damage. Learn more about its role in the pathogenesis of AAV at: https://t.co/YlaCTdxQ2d
#AAV#ANCA#vasculitis#raredisease
"I was afraid of the diagnosisβ¦I started imagining a lot of things." β Martina, MPA
Your patients can hear others' insights into the psychological AAV journey by exploring the new MASTERCLASS modules at https://t.co/VKVpxgjNAc
#AAV#ANCA#vasculitis#raredisease
What do your AAV patients know about the challenges carers face? The new MASTERCLASS modules can offer them detailed insights into the carer's journey, with stories and advice from real AAV carers. Visit: https://t.co/VKVpxgjNAc
#AAV#ANCA#vasculitis#raredisease
With an annual incidence rate of approximately 13β20 cases per million in Europe, AAV is classed as a rare disease. Find out how its most common subtypes vary in commonality across Europe by visiting: https://t.co/QvtYgde9ta
#AAV#ANCA#vasculitis#raredisease
C5a is a protein within the complement system that amplifies ANCA-induced inflammation and vascular damage. Learn more about its role in the pathogenesis of AAV at: https://t.co/YlaCTdynRL
#AAV#ANCA#vasculitis#raredisease
Examine the evidence and crack the clues to identify the prime suspect implicated in the pathophysiology of AAV and educate yourself along the way by trying out the interactive game, Investigate AAV! Visit: https://t.co/h5BMbnEcAy
#AAV#ANCA#vasculitis#raredisease
Kidney involvement is more frequent in patients with Microscopic Polyangiitis (MPA), than those with Granuloma Polyangiitis (GPA). Find out how these frequencies change for other areas of the body at: https://t.co/QvtYgdeHiI
#AAV#ANCA#vasculitis#raredisease